ECGP is thrilled to announce the publication of their recommendations on how to improve patient access to CGP: “The untapped potential of Comprehensive Genomic Profiling”!

These recommendations are developed by ECGP in collaboration with their renowned independent experts and patient advocate Steering Group.

Patient access to comprehensive genomic profiling across Europe remains limited due to various challenges. Through our recommendations, we outline strategies and actionable insights to address them:

ECGP recommendations:

• Improve awareness on the value of Comprehensive Genomic Profiling (CGP)
•  Establish clear funding and reimbursement pathways for technologies like CGP
• Ensure the implementation requirements are realised to ensure patient access to CGP, guidelines, (data) infrastructure, sufficient and capable workforce and stimulating procurement policies.
•  Enhance collaboration among policymakers, industry, healthcare professionals, and patient advocacy groups, to improve access to CG. 

Read the recommendations here: https://www.lungcancereurope.eu/wp-content/uploads/2025/03/Launch-of-the-ECGP-Recommendations.pdf